Activation of Shh signaling is known to be observed following injury of the peripheral nerves such as the sciatic nerve. However, the precise role of Shh signaling during peripheral nerve regeneration is not fully understood. The inferior alveolar nerve (IAN) is most commonly injured during oral surgery. Unlike the sciatic nerve, the IAN is isolated from other craniofacial tissues, as it resides in a long bony canal within the mandible. The IAN is thus an excellent experimental model for investigating peripheral nerve regeneration. In this study, the role of Shh signaling in peripheral nerve regeneration was investigated using the mouse IAN transection model. During regeneration, Shh signaling was activated within the entire distal region of the IAN and proximal stumps. Inhibition of Shh signaling by cyclopamine application at the transection site led to abnormal axon growth in random directions, a reduced number of macrophages, and an increase in myelin debris within the distal region. Shh signaling is thus involved in peripheral nerve regeneration via the regulation of myelin degradation.
Introduction
The peripheral nerve readily regenerates after injury, even when it is completely transected. After injury, Wallerian degeneration occurs distal to the injury site, followed by regeneration of the proximal stump. Schwann cells (SCs) dedifferentiate to proliferate at the distal stump to form an SC column. SCs then recruit macrophages for phagocytosis of the fragmented axons and myelin debris. Furthermore, SCs are involved in promoting axonal growth by the formation of the bands of Büngner, which are an important guide for the regrowth of axons and sprout from the proximal stump of the injured nerve [1] . It is believed that disturbance of the regeneration process leads to abnormal neural function [2, 3] . However, the molecular mechanisms regulating peripheral nerve regeneration are not fully understood.
The Sonic Hedgehog (Shh) signaling pathway plays a critical role in many biological events, including skeleton and limb development. In the absence of its ligand, the pathway receptor Patched 1 (Ptch1) inhibits the signal activator Smoothened (Smo). When bound to its ligand, Ptch1 releases Smo from inhibition, which subsequently activates the glioma-associated oncogene homolog transcription factors (Gli1, Gli2, and Gli3). A ligand of the Shh signaling pathway, Shh is an essential signaling molecule for the development and patterning of the central nervous system [4] [5] [6] . Shh expression has also been reported in injured peripheral nerves, such as the cavernous and sciatic nerves [7] [8] [9] [10] [11] [12] . Nevertheless, the precise role of Shh signaling in peripheral nerve regeneration remains unclear.
The inferior alveolar nerve (IAN)-a branch of the mandibular nerve, which is the third branch of the trigeminal nerve-is sometimes injured during oral surgery, which often leads to unpleasant sensations such as dysesthesia, allodynia, and hyperalgesia that can persist long after injury [13] [14] [15] [16] [17] . However, as knowledge on the pathological mechanisms causing these symptoms is limited, treatments for these nerve dysfunctions have not yet been established. The IAN resides within a long bony cavity, termed the mandibular canal. This anatomical feature is unique to the IAN and is absent in other major nerves used for peripheral nerve regeneration studies, such as the sciatic nerve. As demonstrated by previous findings, this closed environment is ideal for neural regeneration, with the IAN regenerating more rapidly than nerves of other tissues. This suggests that IAN transection is an excellent experimental model for investigating peripheral nerve regeneration [18] [19] [20] . The purpose of this study was thus to investigate the role of Shh signaling in peripheral nerve regeneration, using the IAN transection model.
Materials and methods
All experiments were approved and performed based on the guidelines of Niigata University Intramural Animal Use and Care Committee (approval number #25-329).
Animals and nerve transection
This study used male C57BL6 mice (7-8 weeks) and male mice expressing green fluorescent protein (GFP) under the control of the Shh promoter (Shh-GFP) [21] . Under anesthesia (inhalation of highly concentrated sevoflurane, followed by intraperitoneal injection of 4% chloral hydrate at 2.5 g/kg), the left cheek soft tissue was incised, and the surface of the mandibular bone was removed to expose the IAN. The IAN was completely cut using sharp micro-scissors, and the exposed nerve was immediately brought back to its original position. The exact cutting point of the IAN was determined by the intersection of the line from the corner of the mouth to the center of the ear canal (CM-EC line) and the vertical line from the center of the eye to the CM-EC line. With the intersection as the centerpoint, a 15-mm incision was made along the CM-EC line (Fig. 1A) . All IAN transections were performed only on the left mandibles, with the right side not being used in this study. As a control, intact IANs were obtained from mice that did not undergo nerve transection.
Tissue preparation and immunohistochemistry
Mice were sacrificed at 3 and 7 days after IAN transection by transcardiac perfusion with 4% paraformaldehyde under deep anesthesia (Fig. 1C) . Decalcified sections were sagittally cut at 20 μm thickness in a cryostat. Cryostat sections were incubated with primary antibodies (Gli1, SantaCruz; F4/80, BioRad; protein gene product 9.5 [PGP9.5], Ultra Clone Limited; GFP, Abcam; myelin basic protein [MBP], Abcam). After incubation with primary antibodies, sections were reacted with the appropriate fluorescent-labeled secondary antibodies (fluoresce inisothiocyanate [FITC] and Texas red, Vector) for one hour.
Inhibition of Shh signaling
Twenty-five μl of cyclopamine (final concentration 1 μg/μl; Wako), an antagonist of Smo, was administered at the transected area under anesthesia (inhalation of a high concentration of sevoflurane) every day following surgery using a Hamilton syringe. The needle for cyclopamine administration was inserted at the proximal end of the incision (identified by the suture) and along the CM-EC line (Fig. 1A) . Control animals received 25 μl of physiological saline (PBS). Mice were sacrificed at 3 and 7 days after transection, as mentioned above (Fig. 1C ).
Retrograde tracing in the trigeminal ganglion
To trace regenerated axons, 3 μl of 1,1'-dioctadecyl-3,3,3',3'-tetramethylindocarbocyanine perchlorate (DiI) (Invitrogen) was injected subcutaneously around the mental foramen under anesthesia (inhalation of a high concentration of sevoflurane) 5 days after IAN transection using a Hamilton syringe (Fig. 1B ). Mice were sacrificed 2 days after DiI injection, as mentioned above (Fig. 1C) .
Reverse-transcription polymerase chain reaction (RT-PCR)
Total RNA was extracted from the IAN using Isogen solution (Nippon Gene). RT-PCR was performed using the Access RT-PCR kit (Promega) according to manufacturer's instructions. The sequences of the amplification primers are as follows: MBP (5′-GCGGGGCTCTGGC AAGGACTCACACACG-3′ and 5′-GCGGCTGTCTCTTCCTCCCCAGCTAA ATC-3′); F4/80 (5′-CTTTGGCTATGGGCTTCCAGTC-3′ and 5′-GCAAG GAGGACAGAGTTTATCGTG-3′).
Statistical analysis
Excel Toukei (ver. 6.0; Microsoft, WA) was used for statistical analysis, which was performed using a two-tailed unpaired Student's ttest. The number of DiI-labeled trigeminal ganglion (TG) neurons were compared between the PBS-and cyclopamine-treated animals (n = 4 each). The immunopositive areas for MBP and F4/80 were also compared at the distal region of the transected IAN between PBS and cyclopamine treatments (n = 7 each). P-values of less than 0.05 were considered significant.
Results

Shh signaling activation in the transected IAN
Previous studies have reported that mouse transected IAN axons begin to reconnect by postoperative (PO) day 7, which is consistent with our preliminary findings [19, 20, [22] [23] [24] . We therefore examined IAN regeneration at PO days 3 and 7. To investigate whether Shh signaling is activated during the regeneration of the transected IAN, we examined the expression profiles of Shh and Gli1-a ligand and marker for Shh signaling, respectively-in this region following surgery. We explored immunolocalization at three different regions of the transected IAN (transection site, distal, and proximal; Fig. 2A ). No obvious expression of Gli1 or Shh could be detected in the IAN before transection (Fig. 2B-D and K-M) . At PO day 3, the proximal stumps of the transection sites showed strong Shh expression, while the entire distal region of the IAN including the distal stumps exhibited weak Shh immunoreactivity (Fig. 2F) . Weak expression of Shh was also observed in the distal transected IAN, while it could not be detected in the proximal region of the transected IAN (Fig. 2E, 2G ). Gli1 showed expression patterns similar to those of Shh at PO day 3 although the intensity of Gli1 was higher than those of Shh ( Fig. 2N-P) . At PO day 7, both Shh and Gli1 expression was reduced at all regions of the transected IAN (Fig. 2H-J, Q-S) . Overall, Shh expression was thus similar to that of Gli1 in the transected IAN. These findings indicate that Shh signaling is activated in the transected IAN with a distinct activation pattern in each region at PO day 3.
The role of Shh signaling during IAN regeneration
To further understand the role of Shh signaling during IAN regeneration, we inhibited the signaling pathway by cyclopamine application directly into the transection sites during the regenerative process (Fig. 1C) . Gli1 expression was reduced in the cyclopamine-treated IAN at the proximal stump, where Gli1 is usually expressed, suggesting the down-regulation of Shh signaling activity by the application of cyclopamine (Fig. 3A) . Furthermore, to evaluate whether reduced Shh signaling activity affects axon regeneration, we examined PGP9.5 immunolocalization in the transected IAN with cyclopamine treatment at PO day 7. PGP9.5 immunohistochemistry demonstrated abnormal sprouting axons with random directionality in the cyclopamine-treated IAN (Fig. 3D) . In the distal region of the transected IAN, PGP9.5 immunolocalization was similar between intact and PBS-treated IANs, whereas it was markedly reduced in cyclopamine-treated IANs (Fig. 3E-G) . DiI retrograde tracing analysis was performed to assess reconnection of the axon between the distal and proximal stumps. An injection of DiI around the mental foramen after IAN transection showed a significant reduction in the number of DiI-labeled trigeminal ganglion neurons in cyclopamine-treated IANs (p < 0.05), compared with those of IANs without cyclopamine treatment (Fig. 3H-K) . These findings suggest that reconnection of the transected IAN was compromised due to the abnormal sprouting of axons following cyclopamine application. Reduced Shh signaling thus impaired IAN axon regeneration.
Macrophage recruitment and myelin degradation
In order to investigate whether reduced Shh signaling affects the distal region of the transected IAN, we first examined MBP, a marker for myelin, following cyclopamine treatment. MBP usually disappears from the distal region of the transected IAN at PO day 3 but consistently remained in the cyclopamine-treated IAN (Fig. 4A, B) . The immunohistochemical data was supported by quantitative analysis on MBP-immunopositive areas at the distal region of the transected IAN between the PBS and cyclopamine treatments, with significant difference (Fig. 4C) . These differences could also be seen in RT-PCR analysis (Fig. 4D) . Since myelin is known to be phagocytosed by macrophages at the distal region of injured nerves, we therefore examined F4/80, a marker for macrophages, in the cyclopamine-treated IAN following transection. Although F4/80 immunolocalization usually exists at the distal region of the transected IAN, it was markedly reduced in the cyclopamine-treated IAN (Fig. 4E, F) . RT-PCR analysis also showed the difference between PBS and cyclopamine treatments although quantitative analysis exhibited no significant differences in immunoreactive areas for F4/80 at the distal regions of the transected IANs (Fig. 4G, H) .
Discussion
The findings of the current study indicate the activation of Shh signaling in the transected IAN and the involvement of reduced Shh signaling in abnormal nerve regeneration with the remaining myelin debris. It is therefore reasonable hypothesis that Shh signaling is essential for IAN regeneration. We found that Shh signaling, which is inhibited by cyclopamine, leads to a reduced number of macrophages at the distal region of the transected IAN, with myelin debris remaining. Axons only grow into the distal region when myelin debris is completely degraded [25] , suggesting that myelin clearance by macrophages is an essential process for nerve regeneration [26, 27] . Previous studies have shown that Shh acts as a macrophage chemoattractant in many different types of tissue, such as the gut [28] [29] [30] . It is likely that the myelin debris retained at the distal region through reduced Shh signaling inhibits axon regrowth from the proximal stump, resulting in the abnormal axon sprouting with random orientation observed in this study. Macrophage recruitment is thus likely to be regulated through Shh signaling activation in injured nerves.
Our study clearly demonstrates the differential expression pattern of Shh signaling between the proximal and distal regions of the IAN, including the stumps of transected IANs. The expression of Shh has previously been shown in the neurons of both transected and crushed sciatic nerves [7, 31] . It is possible that Shh signaling is involved in axon growth at the proximal stumps of the transection sites, while it regulates myelin degradation at the distal region. Shh signaling is thus likely to perform distinct roles between the proximal and distal regions of the injured nerve. On the other hand, Shh has also been shown to be expressed in SCs of the crushed sciatic and crushed cavernous nerves [9, 11] . In addition to distinct roles between regions at the site of injury, Shh signaling is potentially activated in different cells by varying levels of damage and/or damage type. Unlike the cavernous or sciatic nerves, the IAN is isolated from other tissues due to its location in the long bony mandibular canal, as well as being insulated from exogenous mechanical and chemical stress during regeneration. The IAN is therefore an excellent model to investigate the direct role of Shh signaling in peripheral nerve regeneration [19, 20] .
Primary cilia are nonmotile organelles that exist on almost all somatic cell surfaces in vertebrates. They have been shown to play critical roles in many biological processes, such as determining left/right axis patterning, regulating signaling pathways, and sensory function, including light, odor, fluid flow, osmolarity changes, and sound [32, 33] . Primary cilia have also been shown to be involved in regulating brain development and brain function [33] [34] [35] . Shh signaling is known to be mediated within primary cilia. It is therefore likely that Shh signaling also regulates peripheral nerve regeneration through the primary cilia.
Dental treatments such as third molar extraction, orthognathic surgery and jaw fracture often damage the IAN [13] [14] [15] [16] [17] . Severe symptoms including the loss of sensation, paresthesia, dysesthesia, allodynia, hyperalgesia, and intractable chronic pain are sometimes observed after IAN injury. Neuroma formation has been regarded as one of the causes inducing these unpleasant symptoms following IAN injury by oral surgeries and jaw fracture [14] [15] [16] [17] . Traumatic neuroma is defined as a non-neoplastic exuberant proliferation of the nerve in response to injury [36] . Microscopically, it consists of a haphazard proliferation of nerve fascicles including axons and SCs. Our findings of abnormal sprouting axons with random orientation during inhibition of Shh signaling recapitulate the morphology of traumatic neuroma. Aberrant Shh signaling has been shown to be involved in many types of acquired diseases including basal cell carcinoma [37] . This raises the possibility that neuroma formation results from the disturbance of molecular mechanisms including the Shh signaling pathway. The IAN transection model thus provides insights into many clinical aspects, from neuropathy onset to developing new therapeutic strategies.
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